维普期刊资源整合服务平台（V6.5）

218篇 您的检索式：作者名="ROSEL D"

选中清除导出查看参考文献查看引证文献引用追踪共11页首页上一页第1页下一页末页 /11 跳转

	题名	作者	年代	出处	被引量
1	Applications of genomics in NSCLC显示文摘	Rosell R Cobo M Isla D		0，，2：	2
2	Single nucleotide polymorphisms and outcome in docetaxel-cisplatin-treated advanced non-small-cell lung cancer显示文摘	Isla D Sarries C Rosell R	2004	Ann Oneol2004，15，8：	1
3	Prognostic value of p53, Ki67, and Rb protein in infiltrating bladder tumors显示文摘	Sanchez Zalabardo D Rosell Costa D Fernandez Montero JM	2002	Actas Urol Esp2002，26，2：	1
4	Antigenic characterization of bovine viral diarrhoea virus isolates from spain with a panel of monoclonal antihodies显示文摘	Vega S Rosell R Paton D J	2000	J Vet Med2000，47，：	1
5	Single nucleotide polymorphisms and outcome in docetaxel-cisplatin-treated advanced non-small-cell lung cancer显示文摘	Isla D Sarries C Rosell R	2004	Ann Oncol2004，15，8：	1
6	Single nucleotide polymorphisms and outcome in docetaxel-cisplatin-treated advanced non small cell lung cancer cancer显示文摘	Isla D Sarries C Rosell R	2004	Ann Oncol2004，15，8：	1
7	Dietary protein degradability effects on plasma and milk urea nitrogen and milk nonprotein nitrogen in Holstein cows显示文摘	Roseler D K Ferguson J D Sniffen C J Herrema J	1993	J Dairy Sci1993，76，2：	1
8	The treatment of advanced gastric cancer:current strategies and future perspectives显示文摘	Cervantes A Rosell S Roda D	2008	Ann Oncol2008，，5：	1
9	ERCC1 mRNA-based randomized phase Ⅲ trial of docetaxel(doc) doublets with cisplatin (cis) or gemcitabine (gem) in stage Ⅳ non-small-cell lung cancer (NSCLC) patients(p)显示文摘	Rosell R Cobo M Isla D		0，，1：	1
10	Ribonucleotide reductase messenger RNA expression and survival in gemcitabine/cisplatintreated advanced non-small cell lung cancer patients显示文摘	Rosell R Danenberg K D Alberola	2004	Clin Cancer Res2004，10，4：	1
11	Single nucleotide polymorphisms and outcome in docetaxel-cisplatin- treated advanced non-small cell lung cancer 显示文摘	Isla D Sarries C Rosell R	2004	Ann Oncol2004，15，8：	1
12	ERCC1 mRNA-based randomized phase Ⅲ trial of docetaxel doublets with cisplatin or gemcitabine in stage Ⅳ non-small-cell lung cancer ( NSCLC ) patients显示文摘	Rosell R Cobo M Isla D	2005	Proc Am Soc Clin Oncol2005，24，：	1
13	ERCC1 mRNA-based ran- domized phase Ⅲ trial of docetaxel (doc) doublets with cisplatin (cis) or gemeitabine (gem) in stagelV non small-cell Lung canc-er (N SCLC) patients 显示文摘	Rosell R Cobo M Isla D	2005	J ClinOncol2005，23，1：	1
14	Transcripts in pretreatment biopsies from a three-arm randomized trial in metastatic non-small-cell lung cancer显示文摘	Rosell R Scagliotti G Danenberg K D	2003	Oncogene2003，22，23：	1
15	Hiarmacogenomics andgemcitabine 显示文摘	Rosell R Cobo M Isla D	2006	Arm Oncol2006，17，5：	1
16	The sweetpotato or silverleaf whiteflies: biotypes of Bemisia tabaci or a species complex显示文摘	Brown J K Frohlich D R Rosell R C	1995	Annu Rev Entomol1995，40，：	1
17	Pharmacogenomics and gemcitabine显示文摘	Rosell R Cobo M Isla D		0，，5：	1
18	Dietary protein degradability effects on plasma and milk urea nitrogen and milk nonprotein nitrogen in Holstein cows显示文摘	Roseler D K		J Dairy Sci0，76，：	1
19	ERCC1 mRNA-based randomized phase Ⅲ trial of docetaxel doublets with cisplatin or gemcitabine in stage Ⅳ non-smal cell lung cancer (NSCLC) patients显示文摘	ROSELL R COBO M ISLA D	2005	Proc Am Soc Clin Oncol2005，24，：	1
20	Up-regulation of Rho/ROCK signaling in sarcoma cells drives invasion and increased generation of protrusive forces显示文摘	ROSEL D BRABEK J TOLDE O	2008	Molecular Cancer Research2008，6，9：	1

返回顶部每页显示：

共11页首页上一页第1页下一页末页 /11 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示